Phase I/II study of ADXS11-001 or MEDI4736 immunotherapies alone and in combination, in patients with recurrent/metastatic cervical or human papillomavirus (HPV)-positive head and neck cancer. (4th November 2015) - Cohen, Ezra EW; Moore, Kathleen N; Slomovitz, Brian M; Chung, Christine H; Anderson, Matthew L; Morris, Shannon R; Mauro, David; Burtness, Barbara